After premedication with oral midazolam, anesthesia was induced using propofol, fentanyl, and atracurium. All operations were performed using intraoperative neurophysiological monitoring with motor and sensory evoked potentials. 20 Standard hemodynamic, fluid balance, and respiratory monitoring were installed, and adequate anesthesia was maintained by a continuous infusion of propofol and remifentanil. Some patients also received S-ketamine (0.25 mg/kg/hr) to supplement intraoperative analgesic management and to enhance monitoring of motor pathways. 19 In children, anesthesia was induced with sevoflurane, fentanyl, and atracurium. After intubation sevoflurane was discontinued, and the intravenous regimen of propofol and remifentanil was used throughout.
After tumor resection a 20-gauge catheter (Multihole Epidural Catheter, Braun Medical Co.) was inserted into the subarachnoid space a little caudal to the resection site, or, in case of low thoracic tumors, cranial to the resection site. Watertight dural closure was commenced using a running locked suture technique (Fig. 1) . Immediately prior to the final closure of the dura, 7 mg/kg morphine was injected under direct visual control; the catheter was removed, and the final stitches were finished to avoid leakage of morphine or CSF.
The morphine dose was calculated based on normal body weight. 27 Doses for overweight children were calculated according to their age and growth percentiles. All patients received a basic standard postoperative pain regimen with acetaminophen, metamizol, and diclofenac as well as postoperative nausea and vomiting prophylaxis with tropisetron and dexamethasone. All patients were extubated immediately after the operation, and they were transferred to the intensive care unit (ICU).
Arrival to the ICU was considered Time 0. At 1, 2, 4, 6, 8, 10, 12, 16, 20, 24, 48 , and 72 hours the following parameters were documented: Numeric Rating Scale (NRS) score 13 for pain assessment, additional morphine needed, side effects attributable to morphine, respiratory rate, oxygen saturation (SaO 2 ), mean arterial blood pressure (MABP), and heart rate.
All patients remained in intensive care overnight and were transferred to a regular patient ward on the 1st postoperative day. All data were collected at the bedside and were transcribed to Excel (Microsoft Corp.) tables for documentation and graphic display. Descriptive statistics and contingency table calculation were performed as appropriate using contingency tables with Fisher's exact test (Excel).
Illustrative Case
A 6-year-old boy with the diagnosis of a cervical intramedullary pilocytic astrocytoma underwent a subtotal resection prior to the introduction of intrathecal morphine analgesia. Postoperative analgesia was based on acetaminophen, metamizol, and patient-controlled intravenous morphine. Pain control was insufficient, with NRS scores at around 4 initially and still 2-3 at 72 hours, resulting in significant discomfort, prolonged high-dose intravenous morphine administration (25 mg/kg/hr), and a 3-day stay in the ICU. About 2 years later the patient underwent resection of a recurrent tumor in the same anatomical setting and the same surgical and care environment. The essential difference was that at this time he was enrolled in the present study and thus received intrathecal morphine in addition to an intravenous morphine drip (20 mg/kg/hr for 12 hours and 10 mg/kg/hr thereafter) and had perfect pain control (NRS Score 0 throughout), no morphine side effects, an uneventful overnight stay in the pediatric ICU, and was transferred to the regular floor on postoperative Day 1.
Results
Twenty patients with cervical and thoracic spinal cord tumors were enrolled in this study, 6 in the cervical group and 14 in the thoracic group. There were no exclusions. Age, spinal level of the injection site, and the total intrathecal morphine dose administered are summarized in Table 1 . The relevant parameters over time separated by cervical and thoracic injection levels are listed in Tables 2 and 3, respectively.
The mean pain scores were between NRS Scores 0 and 1.2, with higher levels upon arrival at the ICU, and a subsequent decline within a small range of scores of 0-3. The pain scores appeared to be slightly lower in cervical than in thoracic injection levels (Tables 2 and 3 ), but these differences were not statistically significant (Table 4) .
There were no complications. The additional amount of intravenous morphine given was minimal. Most extra morphine was needed upon admission to the ICU. The cumulative doses are given in Tables 2 and 3 .
Side effects occurred in 6 patients and are listed in Table 5 . They included nausea, vomiting, and pruritus and were observed after both cervical and thoracic injections. The 2 patients with nausea and vomiting persisting over several hours had cervical injections.
The respiratory rate averaged 10-20 breaths/min in the cervical and 14-16 breaths/min in the thoracic group, the lowest being 7 breaths/min in the thoracic group at 2 hours. The oxygen saturation (with the administration of 2 L of nasal oxygen) averaged between 97% and 99% with a low range to 91% in the cervical and 92% in the thoracic groups. No therapeutic intervention was needed. The MABP and heart rate remained stable within postoperatively expected physiological limits throughout the observation time.
There was no statistically significant difference in incidence of side effects between cervical and thoracic injection levels, and there were no surgical complications such as CSF leakage, infection, or significant neurological deterioration.
Discussion
Extensive surgical exposure of the spine, as required for scoliosis surgery or for resection of spinal cord tumors, causes a large wound surface and particularly causes a loss of muscular attachments on the dorsal elements of the spine. Considering the wide range of movements of the normal cervical spine and the far-reaching muscular connections of the thoracic spine, it is no surprise that such surgical exposure commonly causes significant postoperative pain. Good pain control minimizes suffering and facilitates preservation of normal movement, early postoperative mobilization, and wound healing. 18 Based on our clinical experience of frequently insufficient pain control after spinal cord operations using traditional pain management with acetaminophen, metamizol, and morphine given intravenously by patient-controlled analgesia, we sought improvements to this regimen. Peridural local anesthetics would have required a catheter to remain in the epidural space, with some anesthetic-induced neurological dysfunction. But adequate neurological examination is essential in the immediate postoperative period after spinal cord surgery, and leaving a catheter in the operative field was considered an infection risk. 26 Therefore, this possibility was dismissed in favor of intrathecal administration of morphine. Furthermore, the certainty of intrathecal injection with open catheter placement was considered a significant advantage over peridural infusion. 21 Intrathecally administered opioids are very effective for both acute 4, 7, 8, 17, 31 and chronic 23 pain. This is most likely a result of the direct application of morphine close to spinal receptors and within the blood-brain barrier. The pharmacodynamics and pharmacokinetics 5, 30 of intrathecal opioid injection are known, and there is already considerable experience with postoperative pain control using lumbar intrathecal morphine injection. 11, 12 Since the subarachnoid space is directly accessible in spinal cord surgery, local, i.e., cervical or thoracic, intrathecal injection of morphine was favored over a separate lumbar in- jection. Considering the morphine doses reported 6,7 after lumbar injection and the thoracic and cervical injections sites, a dose of 7 mg/kg normal body weight was chosen for this study. The postoperative 12-24 hours of ICU management and monitoring is our clinical standard and was also considered essential for this study in the context of potential side effects, particularly respiratory depression. 1, 9, 11, 15, 24 The goal of the study was to provide evidence for the clinical impression, as illustrated in the clinical vignette, of an impressive beneficial effect of intrathecal morphine injection directly at the cervical and thoracic resection sites after spinal cord surgery without inhibiting side effects or safety issues.
Analgesia was observed to be satisfactory in the majority of patients at all times during the postoperative observation period. This is particularly so when NRS scores of 3 or lower are considered adequate pain control. 22 Fourteen of the 20 patients had an NRS score of 3 or lower upon ICU admission, 20 of 20 patients after 12 hours, and 17 of 20 patients after 24 hours. The apparent increase in NRS score after 24 hours can be explained by initial mobilization, but it still appears low compared to observations by other groups. 33 The observation of a trend for less pain in the cervical injection group than in the thoracic group was not found to be statistically significant. Whether cervical laminectomy is primarily less painful than thoracic or the effect of the injected morphine is stronger at cervical rather than thoracic levels cannot be elucidated with the present data.
The amount of additional morphine given intravenously on an as-needed basis was minute and of little clinical relevance. In the absence of a control group this finding may serve as a frame of reference in which to place the effect of intrathecal morphine in this setting. Interestingly, both the effect of morphine measured with NRS score and the requirement for additional intravenous morphine remained low beyond 24 hours, even though the effect of intrathecal morphine is reported to last only 18-24 hours. 25 This may be interpreted as a low pain level attributable to very effective pain control in the first 24 hours and avoidance of a vicious pain cycle. It may also be attributable to a Of the known side effects of morphine, only pruritus, nausea, and vomiting occurred. These side effects were mild and transient in all patients but 2 who had persistent nausea and vomiting for several hours. These were patients with cervical injection who had perfect pain control. It could be postulated that the more rostral injection is associated with strong effect and a greater tendency for side effects. Such an association, however, cannot be proved from the data in the present study. Nausea and vomiting transiently raise CSF pressure and thus could cause postoperative leakage. Meticulous watertight closure of the dura and a multilayer watertight wound closure technique are used to prevent this.
Changes in respiratory rate and SaO 2 were mild and remained at levels clinically acceptable in an ICU setting with a spontaneously breathing responsive patient. Both side effects and mild respiratory depression subsided without consequence or further intervention.
Some degree of respiratory depression was to be expected, although it was previously reported with a low incidence of 3%. 11 The transient nature of side effects corresponds to the findings of a recent study about the dose-side effect relationship of intrathecal morphine administration. 9 This study shows that respiratory depression, the most important side effect, occurs but is mild and dose dependent. It has also been reported that respiratory depression resulting from intrathecal morphine administration lasts longer than that from intravenous administration. 1 If respiratory depression were defined as a respiratory rate lower than 8 breaths/min, then this occurred only in a single patient at one time of observation in this study and required no intervention.
Nausea and vomiting occur after both intravenous and intrathecal injection of morphine 11 but constituted no particular problem in this study, neither in terms of significant patient discomfort nor in terms of secondary effects such as CSF leakage. Pruritus, reported in up to one-third of patients receiving lumbar morphine injection, 11 occurred in only 1 patient and also subsided without further consequence.
The routine practice of monitoring patients overnight after surgery in the setting of an ICU was considered essential. Even though no clinical problem or crisis occurred during intensive care monitoring, the availability of an ICU or intermediate care slot remains a prerequisite for postoperative care after intraoperative intrathecal morphine administration. 14 No cardiovascular effects attributable to the intrathecal morphine were observed.
It is known that intrathecal morphine injection in the lumbar spinal canal is effective in immediate and longterm pain control. It was expected that thoracic and cervical direct injection would be no less effective. This study provides evidence for that and in particular also for the safety and surgical suitability of injection not only after lumbar, but also after thoracic and cervical injection. While the effect of intrathecal morphine after lumbar injection has been known and used in spine surgery, it has not been used in spinal cord surgery, and thus opens a safe and effective postoperative pain control regimen for this type of surgery in adults and children.
Conclusions
Intrathecal morphine injected at thoracic and cervical levels provides excellent pain relief without clinically relevant side effects. It seems to be safe as long as the patient can stay overnight in an intensive care setting.
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